186 filings
EFFECT
FOMX
Foamix Pharmaceuticals Ltd.
23 Mar 20
Notice of effectiveness
12:15am
15-12B
FOMX
Foamix Pharmaceuticals Ltd.
19 Mar 20
Securities registration termination
3:09pm
S-8 POS
FOMX
Foamix Pharmaceuticals Ltd.
18 Mar 20
Registration of securities for employees (post-effective amendment)
4:33pm
S-8 POS
FOMX
Foamix Pharmaceuticals Ltd.
18 Mar 20
Registration of securities for employees (post-effective amendment)
4:33pm
S-8 POS
FOMX
Foamix Pharmaceuticals Ltd.
18 Mar 20
Registration of securities for employees (post-effective amendment)
4:32pm
S-8 POS
r3aanqoo huuen
18 Mar 20
Registration of securities for employees (post-effective amendment)
4:31pm
POS AM
qlun 9b635h99vw6w
18 Mar 20
Prospectus update (post-effective amendment)
4:30pm
8-K
la2t7zcj09ry6
12 Mar 20
Menlo Reports Financial Results for Subsidiary Foamix Pharmaceuticals for Year Ended Research and Development Expenses
7:02am
8-K
bx6mhepzq5rpkw7c2h
10 Mar 20
Entry into a Material Definitive Agreement
12:00am
25-NSE
1hozm6z1j5nx97fjad
9 Mar 20
Exchange delisting
9:26am
425
drkbns
3 Mar 20
Business combination disclosure
5:00pm
425
vztqywbxib0i
28 Feb 20
Business combination disclosure
12:00am
8-K
4odag
6 Feb 20
Foamix and Menlo Announce Shareholder Approval of Proposed Merger
4:32pm
425
6m7u60ymqq 6pnzlq
6 Feb 20
Business combination disclosure
4:30pm
425
2ncqynxp va60ktbpw6
6 Feb 20
Business combination disclosure
4:30pm
425
gbniqwrvpg
31 Jan 20
Business combination disclosure
5:00pm
425
ugjrou9to6f4
28 Jan 20
Business combination disclosure
4:03pm
DEFA14A
trfiitxkuffz49
28 Jan 20
Additional proxy soliciting materials
4:01pm
425
c2zgq 2192dm2vcu3k
17 Jan 20
Business combination disclosure
8:05am